Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × vadimezan × Clear all

NCT00111618 2009-01-30

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms